UMP Healthcare Holdings Limited · HKEX:722

UMP Healthcare — FY2022 Earnings Presentation

24 slides from UMP Healthcare's earnings presentation, Sep 28, 2022

  1. Slide 1: FY2022 Annual Results Presentation

    UMP Healthcare Holdings Limited (HKEX: 722) FY2022 Annual Results Presentation 28 September 2022

  2. Slide 2: Disclaimer

    Disclaimer This Presentation has been prepared by UMP Healthcare Holdings Limited (“Company” or the “Group”). does not constitute (i) an offer or invitation for the sale or purchase of the securities, assets or business described herein. This Presentation shall not form the basis of any contract, co

  3. Slide 3: Contents

    Contents 01 Overview & Financial Results 02 Operational Highlights 03 Imaging Market Growth 04 Corporate Outlook 3 FY2022 Annual Results

  4. Slide 4: Overview & Financial Results

    Overview & Financial Results

  5. Slide 5: Company Profile

    Company Profile FY22 Satisfactory Results Hong Kong’s leading private medical service networks Operating Revenue found and managed by doctors HK$665.9m 8% YoY 1,100+ PROVIDERS Network service providers in Operating Profit Hong Kong, Macau & PRC HK$106.6m 25% YoY PATIENTS 1,133,000+ Annual volume o

  6. Slide 6: Results Highlights

    Results Highlights FY22 FY21 YoY +/- FY22 FY21 YoY +/- Operating results HK$’m Financial position HK$’m Operating revenue 665.9 616.4 8% Cash & equivalents 238.1 295.9 (20%) EBITDA 167.1 161.4 4% Shareholders’ funds 698.7 639.5 9% Profit attributable to shareholders 72.2 34.8 107% Per share data HK

  7. Slide 7: Financial Performance

    Financial Performance Year ended 30 June Revenue Profit after tax Basic EPS Dividend per share HK$’m HK$’m HK cents HK cents Final Interim 672.0 622.8 567.4 557.5 75.2 4.5 463.4 9.34 3.8 60.1 7.79 3.3 3.2 2.9 3 37.5 5.04 4.58 31.5 2.8 2.55 2.65 19.5 2.35 1.71 1.5 0.65 0.65 1 0.55 FY18 FY19 FY20 FY21

  8. Slide 8: Operating Segment Revenue

    Operating Segment Revenue Year ended 30 June HK$’m 737.4 725.0 672.3 663.0 649.8 235.2 237.5 246.3 245.6 346.5 622.8 665.9 External sales (Corporate) 567.4 557.5 585.6 430.6 385.3 External sales 321.1 311.9 (Clinical) 239.1 Intersegment sales 86.7 95.6 92.3 102.2 109.2 FY18 FY19 FY20 FY21 FY22 8 Not

  9. Slide 9: Revenue by business lines

    Revenue by business lines 665.9 616.7 HK$’m FY22 FY21 YoY +/- 35% 37% Corporate solution services 235.2 231.1 1.8% Corp Medical Clinical services in Hong Kong & Macau 393.1 348.4 12.8% Clinic Medical Clinic Imaging 33% Clinic Dental • Medical 218.5 204.1 7.1% 33% Mainland • Imaging & Lab 118.9 88.9

  10. Slide 10: Key Expenses to Revenue

    Key Expenses to Revenue FY22 FY21 FY20 % to % to % to HK$’m HK$’m HK$’m Revenue Revenue Revenue Revenue 665.9 616.4 553.1 Professional services expenses 238.0 36% 217.5 35% 215.7 39% Net employee benefit expense 164.7 25% 126.8 21% 129.2 23% Gross employee benefit expense 168.9 25% 141.4 23% 132.2 2

  11. Slide 11: Operational highlights

    Operational highlights

  12. Slide 12: Resilient operating model with diversified sources of income

    Resilient operating model with diversified sources of income Corporate Insurance companies Corporations Scheme Services for their policyholders Services for their employees Solutions or employees of such and/or their dependants Clinical Services in Hong Kong Medical Imaging & lab Dental & Macau Clin

  13. Slide 13: Extensive services network

    Extensive services network As of 30 June 2022 56 Self-owned locations 1,176 Service points HK MO PRC Medical 34 Medical 843 137 89 • General Practice 15 ▪ General Practice 464 105 47 北京 Beijing • Specialists 8 ▪ Specialists & 177 21 40 inpatient treatment • Auxiliary & others 11 ▪ Medical examinatio

  14. Slide 14: Operating Revenue Growth Drivers

    Operating Revenue Growth Drivers Revenue HK$’m Annual volume of FY22 FY21 YoY+/- FY21 Revenue 616.4 YoY+/- clinic visits in FY22 Scheme Solutions 235.2 231.1 1.8% +4.1 849,405 0.2% Medical Services 218.5 204.1 7.1% +14.4 154,751 0.9% Imaging & Lab Services 118.9 88.9 33.8% +30.0 70,526 12.2% Dental

  15. Slide 15: FY2022 Milestones

    FY2022 Milestones AUGUST 2022 MAY 2022 Announced new PET-CT JULY 2021 DEC 2021 Purchased assets & rented centre at BOA Tower, Admiralty Expand headquarter at Launched WeWell B2C One Chinachem Central in Spring 2023 Wing On House, Central membership platform Spread of Omicron & 5th wave of COVID pand

  16. Slide 16: New Multi-service Centre in Central

    New Multi-service Centre in Central Located at Total floor area around One Chinachem Central 21,000 ft2 20/F Oncology treatment 12/F Physiotherapy & rehab 5/F GP & specialists 3/F Preventive health checkup 2/F Diagnostic imaging & lab 1/F Day surgeries 16 Note: Diagram not to scale FY2022 Annual Res

  17. Slide 17: Medical Imaging & Lab Growth & Opportunities

    Medical Imaging & Lab Growth & Opportunities

  18. Slide 18: Hong Kong Diagnostic Imaging Market Dynamics

    Hong Kong Diagnostic Imaging Market Dynamics Long queues in public hospitals and limited market players Median waiting time of non-critical cases Limited private providers in Hong Kong (as of July 2022) at HA hospitals / weeks 86 89 Non-Hospital Hospital 78 66 60 62 PET-CT Scan 12 10 47 51 52 54 52

  19. Slide 19: ProCare Medical Imaging & Lab

    ProCare Medical Imaging & Lab One of the largest private imaging laboratory operators in Hong Kong with 12 service points Cover full line of medical imaging services, including PET, MRI, CT, ultrasound, mammogram, X-ray, etc. Self-owned laboratory ProCare MedTech obtained HOKLAS accreditation for it

  20. Slide 20: New Imaging Centres in Island & Kowloon Areas

    New Imaging Centres in Island & Kowloon Areas Total floor area around Grand opening in 5,500 ft2 2023 Q2 Bank of America Tower @ Central  26 Nathan Road @ Tsimshatsui  Total floor area around Grand opening in 7,5000 ft2 2023 Q1 20 FY2022 Annual Results

  21. Slide 21: Outlook

    Outlook

  22. Slide 22: Macro Trends in Hong Kong & GBA Healthcare Market

    Macro Trends in Hong Kong & GBA Healthcare Market Growing demand for private care Digital healthcare adoption Rising attention on preventive care Cross-border medical service Healthcare talents shortage 22 FY2022 Annual Results

  23. Slide 23: Growth Strategies

    Growth M&A Increase service line-up by horizontal expansion with high potential investment for Strategies business synergies Continue presence in PRC Coordinate specialist referral to national Grade III hospitals, cross-border medical services and outpatient services in existing PPP clinic networks

  24. Slide 24: UMP Healthcare Holdings Limited

    UMP Healthcare Holdings Limited 聯合醫務集團有限公司 HKEX:722 [email protected]

UMP Healthcare Holdings — FY2022 Earnings Presentation on 6ix